Pfizer Inc. (NYSE: PFE), a drug manufacturing company that has earlier revealed that its COVID-19 vaccine candidate has achieved the success of 90% in treating COVID-19 patients has started a pilot delivery program. The corporation has begun this pilot program in the four states of the US including Texas, Tennesse, New Mexico, and Rhode Island.

Pfizer has chosen these sites because of the immunization infrastructure, urban and rural environment, and the diverse population in these states. The company has also clarified that these sites will not get the doses of vaccine ahead of other states because of this pilot program nor, they will get any other compensation. Pfizer and its partner BioNTech have earlier secured the supply agreement of 100 million doses of vaccine from the US government.

Pfizer Inc. (PFE) has seen some recent action in the stock market and its shares closed trading at $35.39 yesterday. Investors are starting to take notice of PFE as the shares traded as high as $37.95 and as low as $36.85 in the last market trading day.

Pfizer Inc. (PFE) average trading volume is 29.06M. However, in the last market trading day Pfizer Inc. (PFE) exchanged 71,660,456 shares. The First downside support level on PFE is $37.27 and the First resistance level on PFE is $41.86. PFE 50-day moving average is $37.00 and PFE 200-day moving average is $36.63.

Pfizer Inc. (PFE) most current performance has been indicated by the recent movement in PFE shares. PFE has performed -1.63% over the past month, PFE has performed -2.69% over the past quarter and PFE has shown 0.13% over the past 12 months. Pfizer Inc. (PFE) has a 52 week range of $27.88 to $41.99. Pfizer Inc. (PFE) is trading 33.90% from its 52 week low and -11.10% from its 52 week high. Pfizer Inc. (PFE) is indicating a 0.83% short float indicating the amount short in the float.

PFE has 5.56B shares outstanding and 5.56B shares in the float. Pfizer Inc. (PFE) presently has a market cap of $201.75B and an income of 8.36B. The EPS next quarter for PFE is 0.60 and the anticipated EPS next year is 16.24%. The market cap of Pfizer Inc. (PFE) at $201.75B represents how many Investors own shares of PFE and is calculated off the last price ($35.39) of PFE and the amount of shares outstanding (5.56B) with Pfizer Inc. (PFE).

Pfizer Inc. (PFE) has aggregate cash (mrq) of 10.52B, aggregate cash per share (mrq) of 1.89, aggregate debt of PFE remains at 63.15B and aggregate debt/equity (mrq) is 96.42. Pfizer Inc. (PFE) operational cash flow (ttm) is 12.55B, PFE leveraged free cash flow (ttm) is -655.25M.

PFE is trading 0.26% above (bullish) its SMA20, 1.48% above (bullish) its SMA50 and 3.59% above (bullish) its SMA200.